Cystatin C identifies chronic kidney disease patients at higher risk for complications.

@article{Peralta2011CystatinCI,
  title={Cystatin C identifies chronic kidney disease patients at higher risk for complications.},
  author={Carmen Peralta and Ronit Katz and Mark J Sarnak and Joachim H. Ix and Linda F. Fried and Ian H de Boer and Walter Palmas and David S Siscovick and Andrew S. Levey and Michael G. Shlipak},
  journal={Journal of the American Society of Nephrology : JASN},
  year={2011},
  volume={22 1},
  pages={147-55}
}
Although cystatin C is a stronger predictor of clinical outcomes associated with CKD than creatinine, the clinical role for cystatin C is unclear. We included 11,909 participants from the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS) and assessed risks for death, cardiovascular events, heart failure, and ESRD among persons categorized into mutually exclusive groups on the basis of the biomarkers that supported a diagnosis of CKD (eGFR <60 ml/min per 1.73… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 80 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 30 references

A more accurate method to estimate glomerular filtration rate from serum CLINICAL EPIDEMIOLOGY www.jasn.org 154 Journal of the American Society of Nephrology

  • AS Levey, JP Bosch, JB Lewis, T Greene, N Rogers, D Roth
  • J Am Soc Nephrol
  • 2011
2 Excerpts

Similar Papers

Loading similar papers…